ALPAY KANITEZ, N. Et Al. 2022. The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database. EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.9, no.4 , 206-211.

ALPAY KANITEZ, N., KİRAZ, S., DALKILIÇ, H. E., KİMYON, G., MERCAN, R., KARADAĞ, Ö., ... BES, C.(2022). The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database. EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.9, no.4, 206-211.

ALPAY KANITEZ, NİLÜFER Et Al. "The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database," EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.9, no.4, 206-211, 2022

ALPAY KANITEZ, NİLÜFER A. Et Al. "The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database." EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.9, no.4, pp.206-211, 2022

ALPAY KANITEZ, N. Et Al. (2022) . "The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database." EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.9, no.4, pp.206-211.

@article{article, author={NİLÜFER ALPAY KANITEZ Et Al. }, title={The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database}, journal={EUROPEAN JOURNAL OF RHEUMATOLOGY}, year=2022, pages={206-211} }